Researchers track rare genetic disorders to prepare for future treatments

NCT ID NCT06555965

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is observing 600 people of any age with STXBP1 or SYNGAP1 gene mutations to better understand how these disorders affect development, seizures, and quality of life. No treatment is given; instead, researchers will collect data from routine clinical assessments over time. The goal is to gather information needed to design future clinical trials for potential therapies.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study will provide crucial data to design future clinical trials for treatments for STXBP1 and SYNGAP1 related disorders.
What could go wrong
This is an observational study with no treatment being tested, so it will not directly improve symptoms. Results depend on consistent participation and data collection over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80011, United States

  • Stanford Medicine Children's Health

    RECRUITING

    Palo Alto, California, 94304, United States

  • Texas Children's Hospital

    RECRUITING

    Houston, Texas, 77030, United States

  • The Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19403, United States

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.